PMID: 9164694May 1, 1997Paper

Tissue plasminogen activator in a vertebral artery dissection

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
A P GaseckiV Hachinski

Abstract

Spontaneous dissection of the vertebral artery is uncommon. Case study. We report a 49-year-old woman who presented with the rapidly progressing basilar artery syndrome who was given an intravenous dose of tissue plasminogen activator seven hours after the onset of first symptoms. Thirty minutes after the injection, a dramatic recovery of the patient's consciousness and neurological signs was noted. To our knowledge, this is the first reported case of intravenous tissue plasminogen activator use in acute vertebral artery dissection.

References

Aug 1, 1975·Neurology·F H HochbergG H Roberson
Oct 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·P HinseL Lachenmayer
Jul 1, 1991·Clinical Cardiology·R Behnam, S Tillinghast
Apr 1, 1990·Stroke; a Journal of Cerebral Circulation·B D YoulM G Bousser
Feb 1, 1990·Journal of Neurosurgery·A YamauraN Saeki
Apr 1, 1989·The American Journal of Cardiology·J I GonzalezC R Conti
Oct 1, 1988·Stroke; a Journal of Cerebral Circulation·W HackeG J del Zoppo
Nov 1, 1987·Stroke; a Journal of Cerebral Circulation·J L MasD Laplane
Jun 1, 1988·Neurology·L R CaplanE S Kwan
Jun 1, 1988·Neurology·B MokriD G Piepgras
Sep 1, 1988·Journal of Neurosurgery·A Yamaura
May 1, 1987·Journal of Neurology·D LeysH Petit
Feb 1, 1987·Archives of Neurology·J BogousslavskyF Regli
Mar 1, 1985·Archives of Neurology·M B KatirjiR E Latchaw
Sep 1, 1983·Angiology·G G NenciE Signorini
Feb 1, 1984·Journal of Neurosurgery·A H Friedman, C G Drake
Jan 1, 1982·Journal of Neurosurgery·H J Senter, M Sarwar
Mar 1, 1982·Stroke; a Journal of Cerebral Circulation·R NassA Chutorian
Dec 1, 1982·Archives of Neurology·H P AdamsS H Cornell
Dec 1, 1982·Archives of Neurology·L KullaT F Mullins
Jan 1, 1981·Stroke; a Journal of Cerebral Circulation·D G ShermanJ D Easton
Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Oct 1, 1994·Catheterization and Cardiovascular Diagnosis·E M BuysH W Plokker
Feb 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·M HuemerG Ladurner
May 1, 1996·Stroke; a Journal of Cerebral Circulation·T BrandtW Hacke
Aug 1, 1996·Stroke; a Journal of Cerebral Circulation·E F Wijdicks, J P Scott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Hospital Medicine
D P de Bono
The New England Journal of Medicine
J Loscalzo, E Braunwald
[Rinshō ketsueki] The Japanese journal of clinical hematology
O Matsuo
The New England Journal of Medicine
Kokyu to junkan. Respiration & circulation
T Matsuda
© 2021 Meta ULC. All rights reserved